Evolus Inc
Evolus Inc (EOLS) Covered Calls
As of September 24, 2026, EOLS has 1 covered call opportunities in the coming three months. Return ranges from 30.0 to 30.0% until expiration. Annualized return ranges from 96.1 to 96.1%. The nearest expiration is January 15, 2027. Maximum potential profit is $240.
Read more
Running EOLS covered calls helps you generate consistent income from Evolus Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Evolus Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best EOLS covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if EOLS stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling EOLS covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Evolus Inc covered call is worth writing.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Income-focused investors, long-term EOLS holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling EOLS covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Evolus Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV percentile36.90% Neutral
- Market cap (M$)519
- 52 weeks high-15.57%
- 52 weeks low103.63%
- Analyst recommendationStrong Buy
1.33 - Target price$15.00
93.55% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E30.82
- EPS (ttm)-0.53
- EPS growth next 5 years—
As of September 24, 2026
| 2027-01-15 | 114 | 10.00 | 25.00 | 0.40 | 0.75 | 240.00 | 30.00 | 96.05 | -5.00 | +0.35 | 1,428 | 0.35 |
As of September 24, 2026
Sell covered calls with the data behind you
Find the best EOLS covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→